Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Preventive Medicine and Hygiene|September 24, 2009
Evaluation of microbial contamination of air in two haematology departments equipped with ventilation systems with different filtration devicesP Crimi, M Valgiusti, G Macrina, et al.The Journal of International Medical Research|October 15, 2005
Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort studyF Ansaldi, V Turello, P Lai, et al.Vaccine|February 13, 2026
Immunogenicity and safety of two doses of the four-component recombinant meningococcal B (4CMenB) vaccine in adults with immunodeficiencyL Sticchi, A Di Biagio, A Domnich, et al.Techniques in Coloproctology|June 28, 2019
Practice parameters for the diagnosis and treatment of anal intraepithelial neoplasia (AIN) on behalf of the Italian Society of Colorectal Surgery (SICCR)G A Binda, G Gagliardi, I Dal Conte, et al.Journal of Preventive Medicine and Hygiene|February 16, 2008
Molecular epidemiology and case-control approaches for management of an outbreak of hepatitis A in Liguria, ItalyF Ansaldi, L Marensi, S Puppo, et al.The Journal of International Medical Research|August 18, 2005
Safety and immunogenicity of conventional subunit and MF59-adjuvanted influenza vaccines in human immunodeficiency virus-1-seropositive patientsG Gabutti, M Guido, P Durando, et al.Journal of Preventive Medicine and Hygiene|December 16, 2010
Hospital-acquired infections and leading pathogens detected in a regional university adult acute-care hospital in Genoa, Liguria, Italy: results from a prevalence studyP Durando, M Bassetti, G Orengo, et al.Clinical and Vaccine Immunology : CVI|November 16, 2007
Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adultsP Durando, D Fenoglio, A Boschini, et al.Pageof 2